Mahathir Bayena

National Energy Services Reunited (NASDAQ:NESR) signed an agreement with Aramco for a lithium demonstration project in Saudi Arabia valued at approximately $200 million.

XPENG (NYSE:XPEV) completed the first production trial of its G9L SUV at Magna’s Graz, Austria facility, making it the fourth XPENG model to undergo production there.

The Australian Taxation Office faces growing political and industry backlash following its announcement to stop accepting credit card tax payments from Dec. 1.

The Australian Banking Association has applied for Australian Competition and Consumer Commission authorisation to let banks collaborate on establishing shared regional hubs.

The ACCC approved the takeover of Grow by Mitsubishi UFJ Financial Group (NYSE:MUFG) for $78 million following operational failures at superannuation fund HESTA.

The Coalition proposed cutting net overseas migration from 292,000 down to 100,000 for two years to reset Australia's temporary visa system.

Safe Pro Group (NASDAQ) expects third-quarter 2026 revenue to exceed $2.5 million, representing growth of more than 2,300% from $101,422 in the same quarter a year earlier.

AbbVie (NYSE:ABBV) received two FDA Breakthrough Therapy Designations for its investigational asset, telisotuzumab adizutecan (Temab-A).

Aehr Test Systems (NASDAQ:AEHR) received approximately $6 million in follow-on production orders for its Sonoma package-level burn-in systems.

Seaport Therapeutics (NASDAQ:SPTX) dosed the first patient in its Phase 2a clinical trial in Australia evaluating GlyphAgo in adults with generalized anxiety disorder and sleep disturbance.